| Edição |
Título |
Arquivo |
| Volume 23, Nº 12 (2023) |
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with Myelofibrosis |
(Eng)
|
|
De S.
|
| Volume 23, Nº 12 (2023) |
NAD+ Consuming Enzymes: Involvement in Therapies and Prevention of Human Diseases |
(Eng)
|
|
Masutani M., Miwa M., Poltronieri P.
|
| Volume 23, Nº 11 (2023) |
Corrigendum to: Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue |
(Eng)
|
|
Galanski M., Keppler B.
|
| Volume 23, Nº 12 (2023) |
New Approaches for the Synthesis N-alkylated Benzo[b]thiophene Derivatives together with their Antiproliferative and Molecular Docking Studies |
(Eng)
|
|
El-Sharkawy K., Mohamed A., Al Farouk F., Mohareb R.
|
| Volume 23, Nº 12 (2023) |
Genotoxicity and Anticancer Effects of the Aminothiophene Derivatives SB-44, SB- 83, and SB-200 in Cancer Cells |
(Eng)
|
|
da Silva E., dos Santos F., de Oliveira J., dos Santos F., Junior F., do Carmo Alves de Lima M., da Rocha Pitta M., de Jesus de Melo Rego M., Pereira M.
|
| Volume 23, Nº 12 (2023) |
Sinularin Exerts Anti-cancer Effects by Inducing Oxidative Stress-mediated Ferroptosis, Apoptosis, and Autophagy in Prostate Cancer Cells |
(Eng)
|
|
Wu Z., Su M., Chen H., Chen X., Chen C., An L., Shao Z., Liu X., Lin Y., OuYang A., Liu C.
|
| Volume 23, Nº 13 (2023) |
Synthesis, Characteristation and Biological Activity of Silver Nanoparticles Generated Using the Leaf and Stembark Extract of Combretum erythrophyllum |
(Eng)
|
|
Bantho S., Naidoo Y., Dewir Y., Singh M., Lin J., Bantho A.
|
| Volume 23, Nº 13 (2023) |
Targeting the LINC00324/miR-16-5p/SEPT2 Signaling Cascade is Effective to Reverse Malignant Phenotypes in Glioblastoma |
(Eng)
|
|
Chen B., Lin P., Li N.
|
| Volume 23, Nº 13 (2023) |
Silybum marianum: An Overview of its Phytochemistry and Pharmacological Activities with Emphasis on Potential Anticancer Properties |
(Eng)
|
|
Nawaz A., Zaib S., Khan I., Ahmed A., Shahzadi K., Riaz H.
|
| Volume 23, Nº 13 (2023) |
Natural Products and Gastric Cancer: Cellular Mechanisms and Effects to Change Cancer Progression |
(Eng)
|
|
Zhao N., Wang W., Jiang H., Qiao Z., Sun S., Wei Y., Xie X., Li H., Bi X., Yang Z.
|
| Volume 23, Nº 13 (2023) |
ADME Prediction, Structure-activity Relationship of Boswellic Acid Scaffold for the Aspect of Anticancer & Anti-inflammatory Potency |
(Eng)
|
|
Kumar A., Sharma S., Mishra S., Ojha S., Upadhyay P.
|
| Volume 23, Nº 13 (2023) |
Germacrone, A Novel and Safe Anticancer Agent from Genus Curcuma: A Review of its Mechanism |
(Eng)
|
|
Lou G., Huang Y., Wang Y., Chen S., Liu C., Li Y., Feng J.
|
| Volume 23, Nº 13 (2023) |
Recent Advancement in the Inhibition of Triple-negative Breast Cancer by N-heterocycles |
(Eng)
|
|
Choudhury B., Chanda K.
|
| Volume 23, Nº 13 (2023) |
Meet the Editorial Board Member |
(Eng)
|
|
Di Benedetto F.
|
| Volume 23, Nº 12 (2023) |
Assessment of Cytotoxic/Antitumour Potential and in silico Study of Salazinic Acid Isolated from Parmotrema concurrens |
(Eng)
|
|
da Conceição de Lira M., da Silva M., Rocha T., de Moura D., Santos Costa E., dos Santos Maia M., Scotti L., Scotti M., de Lourdes Lacerda Buril M., Pereira E., de Aguiar Júnior F., de Britto Lira Nogueira M., da Silva Santos N., da Silva Falcão E., de Melo S.
|
| Volume 23, Nº 11 (2023) |
Corrigendum to: Editorial: Anticancer Platinum Complexes - State of the Art and Future Prospects |
(Eng)
|
|
Galanski M.
|
| Volume 23, Nº 11 (2023) |
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship |
(Eng)
|
|
Hassan O., Kubba A., Tahtamouni L.
|
| Volume 23, Nº 10 (2023) |
Erianin as a Promising Novel Agent in the Treatment of Neuroblastoma: The Anticancer Effects and Underlying Molecular Mechanisms |
(Eng)
|
|
Kocoglu S., Seçme M., Sunay F.
|
| Volume 23, Nº 10 (2023) |
Newly Synthesized Arylazo Derivatives Induce Apoptosis and G2/M Cell Cycle Arrest With Molecular Docking Validation in Human Cancer Cell Lines |
(Eng)
|
|
Laboud Y., Hassan N., Hassaneen H., Hassaneen H., Saleh F., Mohamed Teleb M.
|
| Volume 23, Nº 10 (2023) |
Coumarin and Piperazine Conjugates as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII Isoforms |
(Eng)
|
|
Sethi A., Munagalasetty S., Arifuddin M., Carradori S., Supuran C., Alvala R., Alvala M.
|
| Volume 23, Nº 10 (2023) |
Characterization of Functionalized PLGA Nanoparticles Loaded with Mangiferin and Lupeol, and their Effect on BEAS-2B and HepG2 Cell Lines |
(Eng)
|
|
Fabián R., Mayra H., Manuel Z., Guadalupe S., Alejandro P., Alberto S.
|
| Volume 23, Nº 10 (2023) |
Advancements in Small Molecule PROTACs Containing Indole/Spiro-fused Oxindole Scaffolds: An Emerging Degrader Targeting Cancers |
(Eng)
|
|
Li X., Liu Y., Huang W., Xie X., Zhu H., Peng C., Han B.
|
| Volume 23, Nº 10 (2023) |
Effect of Hybrid Compounds of Stilbene and Pentadienone on Inhibition of Tubulin Polymerization |
(Eng)
|
|
Park J., Koh D., Lee Y., Lim Y., Shin S.
|
| Volume 23, Nº 10 (2023) |
Caracasine, An ent-kaurane Diterpene with Proapoptotic and Pro-differentiator Activity in Human Leukaemia Cell Lines |
(Eng)
|
|
Martínez G., Mijares M., Chávez K., Chirinos P., Suárez A., Compagnone R., De Sanctis J.
|
| Volume 23, Nº 10 (2023) |
Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy |
(Eng)
|
|
De Sanctis J., Charris J., Blanco Z., Ramírez H., Martínez G., Mijares M.
|
| Volume 23, Nº 10 (2023) |
Repurposing of Various Current Medicines as Radioprotective Agents |
(Eng)
|
|
Kaur R., Lang D., Singh H., Arora A., Garg N., Saini B.
|
| Volume 23, Nº 10 (2023) |
Effects of Arctigenin in Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma 5-8F Cells |
(Eng)
|
|
Huang D., Lu R., Cai M., Meng J., He S., Zhang Q., Meng W.
|
| Volume 23, Nº 10 (2023) |
Coumarin-pyrazoline Hybrids as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII |
(Eng)
|
|
Redij A., Carradori S., Petreni A., Supuran C., Toraskar M.
|
| Volume 23, Nº 11 (2023) |
Development of Novel Indole-3-sulfonamide-heteroaryl Hybrids as Carbonic Anhydrase Inhibitors: Design, Synthesis and in-vitro Screening |
(Eng)
|
|
Chinchilli K., Singh P., Swain B., Goud N., Sigalapalli D., Choli A., Angeli A., Nanduri S., Yaddanapudi V., Supuran C., Arifuddin M.
|
| Volume 23, Nº 11 (2023) |
JDHY3 Inhibits Hypopharyngeal Carcinoma Cell Proliferation and Promotes Apoptosis by Inhibiting the PI3K/AKT Pathway |
(Eng)
|
|
Dai W., Ni Z., Zhang G., Xu J., Qin X., Cao J., Liu L.
|
| Volume 23, Nº 11 (2023) |
Gambogic Acid Lysinate-induced Cervical Cancer SiHa Cells Apoptosis in vitro and in vivo |
(Eng)
|
|
Sun J., Liu Y., Guo J., Zhang X., Lin Y., Niu J.
|
| Volume 23, Nº 11 (2023) |
Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells |
(Eng)
|
|
Wang R., Chang C., Chen C., Liu K., Chao J.
|
| Volume 23, Nº 11 (2023) |
Chloroform Fraction of Drymaria cordata Linn (CFDC) Suppresses Estradiol Benzoate- Induced Endometrial Hyperplasia |
(Eng)
|
|
Olowofolahan A., Akinjiola O., Olanlokun J., Oyebode O., Aina O., Olorunsogo O.
|
| Volume 23, Nº 11 (2023) |
Application of Polymer Materials in Targeting Glioma |
(Eng)
|
|
Guo J., Yao Z., Zhang F., Wu J.
|
| Volume 23, Nº 11 (2023) |
Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents |
(Eng)
|
|
Yang J., Lv J., Cheng S., Jing T., Meng T., Huo D., Ma X., Wen R.
|
| Volume 23, Nº 11 (2023) |
Glioblastoma as a Novel Drug Repositioning Target: Updated State |
(Eng)
|
|
Hosseinalizadeh H., Ebrahimi A., Tavakoli A., Monavari S.
|
| Volume 23, Nº 11 (2023) |
Phytochemicals in the Synthetic Era: A Potential Oncosuppressor against Cancer Stem Cells |
(Eng)
|
|
Maru D., Kumar A.
|
| Volume 23, Nº 11 (2023) |
Research Progress on Gene Synthesis and Anticancer and Lipid-lowering Mechanism of Monacolin K |
(Eng)
|
|
Sun Q., Hong H.
|
| Volume 23, Nº 10 (2023) |
New use of Old Drugs: Repurposing of Non-oncology Drugs for Cancer and Oncology Drugs for other Human Diseases |
(Eng)
|
|
Das V.
|
| Volume 23, Nº 18 (2023) |
Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy |
(Eng)
|
|
Shiri Aghbash P., Rasizadeh R., Yari A., Lahouti S., MotieGhader H., Nahand J., Entezari-Maleki T., Baghi H.
|
| Volume 23, Nº 16 (2023) |
Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid Leukemia Based on Integrating Network Pharmacology and Molecular Docking |
(Eng)
|
|
Li H., Jing Y., Chai Y., Sun X., He X., Xue S., Xi Y., Ma X.
|
| Volume 23, Nº 16 (2023) |
MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53 |
(Eng)
|
|
Wang Y., Yin J., Shi X., Zhao X., Li B., Yang M.
|
| Volume 23, Nº 16 (2023) |
STAT3 Signaling Axis and Tamoxifen in Breast Cancer: A Promising Target for Treatment Resistance |
(Eng)
|
|
Zamanian M., Golmohammadi M., Alalak A., Kamiab Z., Obaid R., Ramírez-Coronel A., Hjazi A., Abosaooda M., Mustafa Y., Heidari M., Verma A., Nazari Y., Bazmandegan G.
|
| Volume 23, Nº 16 (2023) |
Managing Cancer Treatment in Patients with Renal Dysfunction: The Role of Chemotherapy |
(Eng)
|
|
Aghsaeifard Z., Alizadeh R.
|
| Volume 23, Nº 16 (2023) |
Fragment-based Drug Discovery Successful Contributions to Current Pharmacotherapeutic Agents Arsenal against Aggressive Cancers: A Mini-Review |
(Eng)
|
|
Santos L., da Silveira N.
|
| Volume 23, Nº 16 (2023) |
Meet the Editorial Board Member |
(Eng)
|
|
Desideri A.
|
| Volume 23, Nº 15 (2023) |
Design of Novel Imidazopyrazine Derivative against Breast Cancer via Targeted NPY1R Antagonist |
(Eng)
|
|
Niranjan V., R V., Philip S., Uttarkar A., Kusanur R., Kumar J.
|
| Volume 23, Nº 15 (2023) |
Surface Modification of Poly(lactide-co-glycolide) Nanoparticles for the Sustained in vitro Release and the Enhanced Cytotoxicity of Chelidonine |
(Eng)
|
|
Hamidia Z., Shahanipour K., Talebian N., Monajemi R.
|
| Volume 23, Nº 15 (2023) |
Schisandrin B Inhibits Cell Viability and Malignant Progression of Melanoma Cells via Wnt/β-catenin Signaling Pathway |
(Eng)
|
|
Chen J., Zhang L., Pu Y., Chen Y., Li Y., Pan X., Chen J.
|
| Volume 23, Nº 15 (2023) |
Proteomics Analysis Revealed Smad3 as a Potential Target of the Synergistic Antitumor Activity of Disulfiram and Cisplatin in Ovarian Cancer |
(Eng)
|
|
Du R., Sun F., Li K., Qi J., Zhong W., Wang W., Sun Q., Deng Q., Wang H., Nie J., Ding C., Hong B.
|
| Volume 23, Nº 15 (2023) |
KRAS Mutation Reduces Thymoquinone Anticancer Effects on Viability of Cells and Apoptosis |
(Eng)
|
|
Betul Yenigun V., Acar H., Kanimdan E., Yenigun A., Kocyigit A., Cora T.
|
| Volume 23, Nº 16 (2023) |
Synthesis of S-2-phenylchromane Derivatives and Evaluation of the Antiproliferative Properties as Apoptosis Inducers in Cancer Cell Lines |
(Eng)
|
|
Zhang Y., Ma J., Pei Y., Xie Z., Fu D., Li J.
|
| Volume 23, Nº 16 (2023) |
Chemical Constituents from the Roots of Jasminum sambac (L.) Ait. and their Cytotoxicity to the Cancer Cell Lines |
(Eng)
|
|
Olatunde O., Yong J., Lu C.
|
| Volume 23, Nº 16 (2023) |
Design and Evaluation of SLNs Encapsulated Curcumin-based Topical Formulation for the Management of Cervical Cancer |
(Eng)
|
|
Singhai M., Pandey V., Ashique S., Gupta G., Arora D., Haider T., Mishra N.
|
| Volume 23, Nº 18 (2023) |
Quercetin-based Nanoformulation: A Potential Approach for Cancer Treatment |
(Eng)
|
|
Shivani ., Singh G., Narwal S., Chopra B., Dhingra A.
|
| Volume 23, Nº 17 (2023) |
The Cytotoxic and Anti-tumor Potential of Methanolic Extracts of Indian Marine Isolates in HCT116 Colorectal Cancer Cells |
(Eng)
|
|
A S., Sekar S., Kasinathan K., KN A.
|
| Volume 23, Nº 17 (2023) |
Prebiotics Modulate Gut Microbiota-mediated T-cell Immunity to Enhance the Inhibitory Effect of Sintilimab in Lewis Lung Adenocarcinoma Model Mice |
(Eng)
|
|
Yan Q., Su S., Dai G., He L.
|
| Volume 23, Nº 17 (2023) |
Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells |
(Eng)
|
|
Serttas R., Erdogan S.
|
| Volume 23, Nº 17 (2023) |
Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma |
(Eng)
|
|
Su C., Li M., Yang Y., Wang Z., Wang Q., Wang W., Ma X., Jie R., Chen H., Li X., Lu J.
|
| Volume 23, Nº 17 (2023) |
Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids via the EGFR Inhibition Pathway |
(Eng)
|
|
Hisham M., Hassan H., Gomaa H., Youssif B., Hayalah A., Abdel-Aziz M.
|
| Volume 23, Nº 17 (2023) |
Novel Synthetic Indazoles Abrogate Angiogenesis in Erlich Ascites Tumor Bearing Mice |
(Eng)
|
|
Ashwini N., Balaji K., Sadashivaiah B., Swaroop T., Jayarama S., Mantelingu K., Rangappa K.
|
| Volume 23, Nº 17 (2023) |
Crocin Suppresses Colorectal Cancer Cell Proliferation by Regulating miR-143/145 and KRAS/RREB1 Pathways |
(Eng)
|
|
Hosseini S., Nazifi P., Amini M., Zargari F., Yari A., Baradaran B., Mahboob S., Mokhtarzadeh A.
|
| Volume 23, Nº 17 (2023) |
Four Decades of the Comet Assay: pH Optimum of Lysis Buffer Still Needs to be Elucidated |
(Eng)
|
|
Heneberg P.
|
| Volume 23, Nº 17 (2023) |
Intermittent Fasting against Cancer Development and Progression: Highlighting Potential Anticancer Molecular Mechanisms |
(Eng)
|
|
Psara E., Poulios E., Papadopoulou S., Tolia M., Vasios G., Giaginis C.
|
| Volume 23, Nº 16 (2023) |
Shikonin Causes Non-apoptotic Cell Death in B16F10 Melanoma |
(Eng)
|
|
Ahmad H., Crotts M., Jacobs J., Baer R., Cox J.
|
| Volume 23, Nº 15 (2023) |
Synthesis and in vitro Anti-proliferative Activities on LNCaP, LS180 and MKN45 of Novel 20(R)-Panaxadiol Derivatives |
(Eng)
|
|
Deng J., Yang X., Luan M., Liu S., Zhang J., Jiang S., Wang W., Hou G., Meng Q., Wang H.
|
| Volume 23, Nº 15 (2023) |
Investigating the Anti-tumor and Apoptosis-inducing Effects of Coumarin Derivatives as Potent 15-Lipoxygenase Inhibitors on PC-3 Prostate Cancer Cells |
(Eng)
|
|
Maleki F., Sadeghian H., Bahrami A., Goftari S., Matin M.
|
| Volume 23, Nº 14 (2023) |
Berbamine Inhibits the Biological Activities of Prostate Cancer Cells by Modulating the ROS/NF-κB Axis |
(Eng)
|
|
Zhao W., Jiang Y., Jia X., Wang X., Guo Y.
|
| Volume 23, Nº 14 (2023) |
Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds |
(Eng)
|
|
Xiaohelaiti H., Wu W., Gao Y., Li S., Ma C.
|
| Volume 23, Nº 13 (2023) |
Triptolide Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Akt/mTOR Pathway |
(Eng)
|
|
Zheng Z., Yan G., Xi N., Xu X., Zeng Q., Wu Y., Zheng Y., Zhang G., Wang X.
|
| Volume 23, Nº 14 (2023) |
Enrichment of Isaria felina Culture with Selenium Enhances its in vivo Antitumor Effects on H22 Hepatoma via Decreasing the Expression of VEGF |
(Eng)
|
|
Yang X., Yang Y., Zhao L., Chen L., Wang J., Yan L., Ma J.
|
| Volume 23, Nº 14 (2023) |
Meet the Editorial Board Member |
(Eng)
|
|
Chen Y.
|
| Volume 23, Nº 14 (2023) |
Carbon Nanotubes in Breast Cancer Treatment: An Insight into Properties, Functionalization, and Toxicity |
(Eng)
|
|
Srivastava N., Mishra Y., Mishra V., Ranjan A., Tambuwala M.
|
| Volume 23, Nº 14 (2023) |
Diosgenin Glucoside Inhibits the Progression of Osteosarcoma MG-63 by Regulating the PI3K/AKT/mTOR Pathway |
(Eng)
|
|
Ruan S., Gu L., Wang Y., Huang X., Cao H.
|
| Volume 23, Nº 14 (2023) |
The Effect of Iron Oxide Nanoparticles of Acalypha wilkesiana Ethyl Acetate Extract on Ehrlich Ascites Carcinoma Cells |
(Eng)
|
|
Moustafa A., Abd El-Hamid El-Damrany M., Youssef M.
|
| Volume 23, Nº 14 (2023) |
Diterpenoid Tanshinone Attenuates the Metastasis of Non-small-cell Lung Cancer (NSCLC) Cells by Inhibiting the Cavin-1-mediated ERK/Smad2 Signaling Pathway |
(Eng)
|
|
Wang L., Jiang G., Li X.
|
| Volume 23, Nº 14 (2023) |
Synthesis and Characterization of Novel 4-aryl-4H-chromene Derivatives using Borax and Evaluation of their Anticancer Effects |
(Eng)
|
|
Adibi H., Hosseinzadeh L., Amirafshari M., Jalilian F.
|
| Volume 23, Nº 13 (2023) |
ALK and ERBB2 Protein Inhibition is Involved in the Prevention of Lung Cancer Development by Vincamine |
(Eng)
|
|
Verma A., Yadav P., Rajput S., Verma S., Arora S., Kumar R., Bhatti J., Khurana A., Navik U.
|
| Volume 23, Nº 15 (2023) |
Meet the Editorial Board Member |
(Eng)
|
|
Adhikari A.
|
| Volume 23, Nº 14 (2023) |
Novel Arcyriaflavin-A Derivatives as PIM Kinase Inhibitors for Treating Cancer |
(Eng)
|
|
De S.
|
| Volume 23, Nº 14 (2023) |
VEGFR2 Mimicking Peptide Inhibits the Proliferation of Human Umbilical Vein Endothelial Cells (Huvecs) by Blocking VEGF |
(Eng)
|
|
Ghasemali S., Barzegar A., Farajnia S., Rahmati M., Negahdari B., Etemadi A., Nazari A.
|
| Volume 23, Nº 15 (2023) |
Antitumor Mechanisms of Molecules Secreted by Trypanosoma cruzi in Colon and Breast Cancer: A Review |
(Eng)
|
|
Sadr S., Ghiassi S., Lotfalizadeh N., Simab P., Hajjafari A., Borji H.
|
| Volume 23, Nº 13 (2023) |
p-Coumaric Acid Inhibits Osteosarcoma Growth by Inhibiting PI3K/Akt Signaling Pathway |
(Eng)
|
|
Yang B., Wang B., Wang G., Cao W., Wang Q., Pu H., An W.
|
| Volume 23, Nº 15 (2023) |
Cardiotoxicity of Targeted Therapies in Children with Haematological Malignancies and Solid Tumors |
(Eng)
|
|
Bangeas A., Tragiannidis A.
|
| Volume 22, Nº 6 (2022) |
New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range |
(Eng)
|
|
Mavrova A., Dimov S., Yancheva D., Rangelov M., Wesselinova D., Naydenova E.
|
| Volume 22, Nº 11 (2022) |
Propofol and Sevoflurane Alleviate Malignant Biological Behavior and Cisplatin Resistance of Xuanwei Lung Adenocarcinoma by Modulating the Wnt/β-catenin Pathway and PI3K/AKT Pathway |
(Eng)
|
|
Quan Y., Li S., Wang Y., Liu G., Lv Z., Wang Z.
|
| Volume 22, Nº 10 (2022) |
Chemical Constituents and Antitumor Mechanisms of Artemisia |
(Eng)
|
|
Kamarya Y., Lijie X., Jinyao L.
|
| Volume 21, Nº 9 (2021) |
Retracted: The Natural Flavonoid Naringenin Inhibits the Cell Growth of Wilms Tumor in Children by Suppressing TLR4/NF-κB Signaling |
(Eng)
|
|
Li H., Chen P., Chen L., Wang X.
|
| Volume 21, Nº 2 (2021) |
Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol |
(Eng)
|
|
Nkune N., Kruger C., Abrahamse H.
|
| Volume 16, Nº 1 (2016) |
Meet Our Editorial Board Member: |
(Eng)
|
|
Folini M.
|
| Volume 16, Nº 10 (2016) |
Inhibitors of Cancer Stem Cells |
(Eng)
|
|
García-Rubiño M., Lozano-López C., Campos J.
|
| Volume 16, Nº 10 (2016) |
Diazenyl Derivatives and their Complexes as Anticancer Agents |
(Eng)
|
|
Kaur H., Yadav S., Narasimhan B.
|
| Volume 16, Nº 10 (2016) |
Synthesis of Diflunisal Thiazolidinones as Anticancer Agents |
(Eng)
|
|
Şenkardeş S., Özakpınar Ö., Özsavcı D., Şener A., Çevik Ö., Küçükgüzel Ş.
|
| Volume 16, Nº 10 (2016) |
Targeting the Folate Receptor: Effects of Conjugating Folic Acid to DOX Loaded Polymeric Micelles |
(Eng)
|
|
Elkhodiry M., Husseini G., Velluto D.
|
| Volume 16, Nº 10 (2016) |
Investigation of Fucoidan-Oleic Acid Conjugate for Delivery of Curcumin and Paclitaxel |
(Eng)
|
|
Phan U., Nguyen K., Vo T., Duan W., Tran P., Tran T.
|
| Volume 16, Nº 10 (2016) |
Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents |
(Eng)
|
|
Küçükgüzel Ş., Coşkun G.
|
| Volume 16, Nº 10 (2016) |
1,3,4-Thiadiazole Based Anticancer Agents |
(Eng)
|
|
Aliabadi A.
|
| Volume 16, Nº 10 (2016) |
Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer Agents |
(Eng)
|
|
Yu B., Zheng Y., Shi X., Qi P., Liu H.
|
| Volume 16, Nº 10 (2016) |
Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site |
(Eng)
|
|
Wu X., Wang Q., Li W.
|
| Volume 16, Nº 10 (2016) |
Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery |
(Eng)
|
|
Pinheiro A., Mendonça Nogueira T., de Souza M.
|
| 201 - 300 de 1156 resultados |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 > >>
|
